Canaccord analyst Matt Bottomley lowered the firm’s price target on Tilray to $5 from $7 and keeps a Buy rating on the shares. The analyst target cut comes following a weaker-than-anticipated FQ2/23 print in addition to the recent softening of US federal catalysts following the conclusion of the congressional lame-duck session, which ultimately did not advance any cannabis reforms.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TLRY:
- SweetWater Brewing Company Celebrates 26 Years of Brewing with Throwback Beers, Jam Bands
- Tilray price target lowered to $3 from $4 at Alliance Global Partners
- Tilray Tanks on Tepid Q2 Numbers
- Largest borrow rate increases among liquid names
- Tilray Brands Reports Second Quarter Fiscal Year 2023 Financial Results
